A carregar...

Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases

The 90 kDa heat shock protein (Hsp90) has become a validated target for the development of anti-cancer agents. Several Hsp90 inhibitors are currently under clinical trial investigation for the treatment of cancer. All of these agents inhibit Hsp90’s protein folding activity by binding to the N-termi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brandt, Gary E. L., Blagg, Brian S. J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2853258/
https://ncbi.nlm.nih.gov/pubmed/19860731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!